Tysabri Safe and Effective Taken Every 6 Weeks, NOVA Trial Finds

Tysabri Safe and Effective Taken Every 6 Weeks, NOVA Trial Finds

301553

Tysabri Safe and Effective Taken Every 6 Weeks, NOVA Trial Finds

Tysabri (natalizumab) given every six weeks was as safe and effective over nearly 1.5 years of use as its approved four-week dosing in people with relapsing-remitting multiple sclerosis (RRMS), according to top-line data from the Phase 3b NOVA study. Tysabri is typically administered every four weeks, or about once per month. But emerging evidence indicates that less frequent dosing could maintain efficacy while lowering the risk of side effects, including the rare but serious brain…

You must be logged in to read/download the full post.